David Meeker Insider Profile

4 Followers
David Meeker, Director at Savient Pharmaceuticals, holds 12.64K shares in Savient Pharmaceuticals (Ticker: SVNTQ), holds 2.30K shares in MyoKardia (Ticker: MYOK), holds 352.49K shares in Trevi Therapeutics (Ticker: TRVI).
tipranks
David Meeker

David Meeker
Savient Pharmaceuticals (SVNTQ)
Director

Ranked #83,646 out of 99,218 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-37.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
88.97%
11.03%
A breakdown of David Meeker's holdings

Insider Roles

Rhythm Pharmaceuticals
(RYTM)
President & CEO, Director
Trevi Therapeutics
(TRVI)
Director
Roles that David Meeker holds in companies

Most Profitable Insider Trade

Stock:
Trevi Therapeutics
(TRVI)
Rating:Informative Sell
Date:Aug 29, 2024 - Today
Return:-3.40%
The most profitable trade made by David Meeker

David Meeker's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SVNTQ
Savient Pharmaceuticals
Jan 09, 2013
Uninformative Buy
MYOK
MyoKardia
$517.29K
Rhythm Pharmaceuticals
Mar 19, 2024
President & CEO, Director
Uninformative Sell
1.78M
$8.56M
Trevi Therapeutics
Aug 29, 2024
Director
Uninformative Buy
6.51K
$1.06M
List of latest transactions for each holding click on a transaction to see David Meeker's performance on stock

David Meeker insider profile FAQ

What is the percentage of profitable transactions made by David Meeker?
The percentage of profitable transactions made by David Meeker is 0%.
    What is the average return per transaction made by David Meeker?
    The average return per transaction made by David Meeker is -37.90%.
      What stocks does David Meeker hold?
      David Meeker holds: SVNTQ, MYOK, RYTM, TRVI stocks.
        What was David Meeker’s latest transaction?
        David Meeker latest transaction was an Uninformative Buy of ―.
          What was David Meeker's most profitable transaction?
          David Meeker’s most profitable transaction was an Informative Sell of TRVI stock on August 29, 2024. The return on the trade was -3.40%.
            What is David Meeker's role in Savient Pharmaceuticals?
            David Meeker's role in Savient Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.